Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Part D PAPs inconsistent

Executive Summary

Availability and assistance from pharmaceutical assistance programs sponsored by states and drug makers are uneven, according to GAO. Its Sept. 5 report finds that only 23 states currently offer 37 qualified programs; eligibility and the type and extent of assistance vary between programs, with 20 programs offering broadly defined assistance, while 14 are aimed at a specific disease or condition. Manufacturer-sponsored PAPs also vary in eligibility requirements and application process, GAO notes, and are typically limited to the drugs that the manufacturer produces
UsernamePublicRestriction

Register

PS050075

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel